These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 28097711)

  • 21. Pharmacists' perceptions of their practice: a comparison between Alberta and Northern Ireland.
    Al Hamarneh YN; Rosenthal M; McElnay JC; Tsuyuki RT
    Int J Pharm Pract; 2012 Feb; 20(1):57-64. PubMed ID: 22236181
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The introduction of the national e-health record into Australian community pharmacy practice: pharmacists' perceptions.
    Mooranian A; Emmerton L; Hattingh L
    Int J Pharm Pract; 2013 Dec; 21(6):405-12. PubMed ID: 23560554
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pay-for-performance model of medication therapy management in pharmacy practice.
    Lenz TL; Monaghan MS
    J Am Pharm Assoc (2003); 2011; 51(3):425-31. PubMed ID: 21555297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Nationwide Study of Pharmacists' Perception of the Impact of Medicare Part D on the Pharmacist-Patient Relationship.
    Spooner JJ; Spotts H; Khan S
    Consult Pharm; 2017 Oct; 32(10):629-644. PubMed ID: 28992824
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacist and physician perspectives on diabetes service delivery within community pharmacies in Indonesia: a qualitative study.
    Wibowo Y; Sunderland B; Hughes J
    Int J Pharm Pract; 2016 May; 24(3):180-8. PubMed ID: 26670327
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Views and experiences of community pharmacists and superintendent pharmacists regarding the New Medicine Service in England prior to implementation.
    Wells KM; Thornley T; Boyd MJ; Boardman HF
    Res Social Adm Pharm; 2014; 10(1):58-71. PubMed ID: 23608701
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Community pharmacists' experience and perceptions of the New Medicines Service (NMS).
    Lucas B; Blenkinsopp A
    Int J Pharm Pract; 2015 Dec; 23(6):399-406. PubMed ID: 25712253
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Paying for quality not quantity: a wisconsin health maintenance organization proposes an incentive model for reimbursement of chiropractic services.
    Pursel KJ; Jacobson M; Stephenson K
    J Manipulative Physiol Ther; 2012 Jul; 35(6):472-6. PubMed ID: 22926019
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cross-sector, sessional employment of pharmacists in rural hospitals in Australia and New Zealand: a qualitative study exploring pharmacists' perceptions and experiences.
    Tan AC; Emmerton LM; Hattingh HL; La Caze A
    BMC Health Serv Res; 2014 Nov; 14():567. PubMed ID: 25391333
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How to enhance public health service utilization in community pharmacy?: general public and health providers' perspectives.
    Saramunee K; Krska J; Mackridge A; Richards J; Suttajit S; Phillips-Howard P
    Res Social Adm Pharm; 2014; 10(2):272-84. PubMed ID: 23089293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of perceived impact on relationship quality in pharmacists' willingness to influence indication-based off-label prescribing decisions.
    Basak R; Bentley JP; McCaffrey DJ; Bouldin AS; Banahan BF
    Soc Sci Med; 2015 May; 132():181-9. PubMed ID: 25818379
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medical ethics: enhanced or undermined by modes of payment?
    Zweifel P; Janus K
    Eur J Health Econ; 2017 Jan; 18(1):119-129. PubMed ID: 27072055
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Initial perceptions of key stakeholders in Ontario regarding independent prescriptive authority for pharmacists.
    Pojskic N; MacKeigan L; Boon H; Austin Z
    Res Social Adm Pharm; 2014; 10(2):341-54. PubMed ID: 23816494
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Link between pay for performance incentives and physician payment mechanisms: evidence from the diabetes management incentive in Ontario.
    Kantarevic J; Kralj B
    Health Econ; 2013 Dec; 22(12):1417-39. PubMed ID: 23203722
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacist-industry relationships.
    Saavedra K; O'Connor B; Fugh-Berman A
    Int J Pharm Pract; 2017 Dec; 25(6):401-410. PubMed ID: 28097713
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advanced-practice pharmacists: practice characteristics and reimbursement of pharmacists certified for collaborative clinical practice in New Mexico and North Carolina.
    Murawski M; Villa KR; Dole EJ; Ives TJ; Tinker D; Colucci VJ; Perdiew J
    Am J Health Syst Pharm; 2011 Dec; 68(24):2341-50. PubMed ID: 22135061
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Perspectives of pharmacists about collaborative asthma care model in primary care.
    Qazi A; Saba M; Armour C; Saini B
    Res Social Adm Pharm; 2021 Feb; 17(2):388-397. PubMed ID: 32284301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Facilitators for practice change in Spanish community pharmacy.
    Gastelurrutia MA; Benrimoj SI; Castrillon CC; de Amezua MJ; Fernandez-Llimos F; Faus MJ
    Pharm World Sci; 2009 Feb; 31(1):32-9. PubMed ID: 18998235
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Integrated primary care insomnia management in Australia.
    Sake FT; Wong K; Bartlett DJ; Saini B
    Res Social Adm Pharm; 2018 Feb; 14(2):170-179. PubMed ID: 28262515
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and implementation of the compensation plan for pharmacy services in Alberta, Canada.
    Breault RR; Whissell JG; Hughes CA; Schindel TJ
    J Am Pharm Assoc (2003); 2017; 57(4):532-541. PubMed ID: 28623124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.